Invesaro

Stocks Health care CFOR

OTC · Health care

CapForce Inc. (CFOR)

In fiscal 2025 capital spending exceeded operating cash flow by $1.2M. At June 30, 2026 it held $143.8K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 19, 2026.

Watch CFOR in 60 seconds
Price
$4.04
0.00% on the day · September 25, 2026
52-week range $0.00 to $34.00
Market cap
$50.1M
P/E
1.7
on FY2025 diluted EPS

What CapForce Inc. does

CapForce Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on OTC under the ticker CFOR.

Revenue and profit by year

Revenue
FY18: $2.9M $2.9M FY18FY19: $3.5M $3.5M FY19FY20: $4.2M $4.2M FY20FY21: $4.3M $4.3M FY21FY22: $2.6M $2.6M FY22FY23: $3.4M $3.4M FY23FY24: $5.2M $5.2M FY24FY25: $30.2M $30.2M FY25
Net income
FY18: -$13.4M -$13.4M FY18FY19: -$12.4M -$12.4M FY19FY20: -$26.2M -$26.2M FY20FY21: -$34.8M -$34.8M FY21FY22: -$37.3M -$37.3M FY22FY23: -$32.7M -$32.7M FY23FY24: $12M $12M FY24FY25: $23.6M $23.6M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$30.2M$24M$23.6M$2.32-$1.2M
2024$5.2M$324.7K$12M$2.30n/a
2023$3.4M-$30.7M-$32.7M-$41.47-$15.1M
2022$2.6M-$34.6M-$37.3M-$152.70-$21M
2021$4.3M-$23.3M-$34.8M-$228.90-$23.5M
2020$4.2M-$22.7M-$26.2M-$333.31-$23.5M

Full financial statements: income, balance sheet and cash flow

Next report expected around September 30, 2026.

Estimated from its filing rhythm: 52 weeks after its report of October 1, 2025. Not a date the company has announced. See the report calendar

Where CFOR ranks in Health care

Revenue$30.2M
#450 of 742 in Health care · Bottom 39%
Revenue growth+481.2%
#18 of 529 in Health care · Top 3%
Net margin78.2%
#7 of 541 in Health care · Top 1%
Free cash flow margin-4.1%
#272 of 488 in Health care · Bottom 44%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What CapForce Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 19, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 1,150% to $50M versus the same quarter last year; diluted EPS $3.38 versus $0.34.
  2. August 14, 2026
  3. June 12, 2026
    Quarterly report 10-Q · period to March 31, 2026Diluted EPS -$0.06 versus -$0.04.
  4. May 26, 2026
    Annual report 10-K · period to December 31, 2025Revenue rose 481% to $30.2M versus the prior year; diluted EPS $2.32 versus $2.30.
  5. May 15, 2026
  6. March 31, 2026
  7. February 27, 2026
  8. February 6, 2026
  9. January 26, 2026
  10. January 16, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 6, 2026. Insider transactions on SEC

Insider trades

What the people running CapForce Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
February 23, 2026 Wong Poh Yin ConstanceDirector Received as pay 5,555 - - Form 4
February 23, 2026 Low Yu Jie EthanDirector Received as pay 5,555 - - Form 4
February 23, 2026 Yee Gillian Tan RouCorporate Secretary Received as pay 2,778 - - Form 4
February 23, 2026 Lim Zhao Qi KenDirector Received as pay 5,555 - - Form 4
February 23, 2026 Azudin Mohd AzhamCOO Received as pay 5,555 - - Form 4
February 23, 2026 Chua Kok Hoe VictorDirector Received as pay 5,555 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns CFOR

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

We have not read this company's Schedule 13D and 13G filings yet.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

6 insiders reported holding 191,712 shares in total, about $774.5K at the last price.

HolderSharesAs of
Azudin Mohd AzhamCOO 36,805 February 23, 2026
Wong Poh Yin ConstanceDirector 34,126 February 23, 2026
Lim Zhao Qi KenDirector 34,126 February 23, 2026
Low Yu Jie EthanDirector 34,126 February 23, 2026
Chua Kok Hoe VictorDirector 34,126 February 23, 2026
Yee Gillian Tan RouCorporate Secretary 18,403 February 23, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CFOR

What does CapForce Inc. do?

CapForce Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on OTC under the ticker CFOR.

Is CapForce Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $62.3M.

When did CapForce Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 19, 2026. It covers the period to June 30, 2026.

Similar companies

Compare CFOR with

Compare CFOR with any company

Follow CFOR

Get an email when CapForce Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CFOR: get an email when it files

Where the numbers come from

Financial figures are the values CapForce Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.